SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,515 | +21.0% | 3,733 | +14.3% | 0.01% | +40.0% |
| Q2 2023 | $373,907 | +71.5% | 3,265 | +155.7% | 0.01% | +25.0% |
| Q4 2020 | $218,000 | +3.8% | 1,277 | -14.2% | 0.00% | 0.0% |
| Q3 2020 | $210,000 | +556.2% | 1,489 | +365.3% | 0.00% | +300.0% |
| Q1 2020 | $32,000 | -23.8% | 320 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $42,000 | +68.0% | 327 | -0.6% | 0.00% | 0.0% |
| Q3 2019 | $25,000 | -50.0% | 329 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $50,000 | +19.0% | 328 | -7.9% | 0.00% | 0.0% |
| Q1 2019 | $42,000 | -17.6% | 356 | -23.6% | 0.00% | 0.0% |
| Q4 2018 | $51,000 | +1175.0% | 466 | +370.7% | 0.00% | – |
| Q3 2017 | $4,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |